Literature DB >> 17618270

Skeletal remodeling in health and disease.

Mone Zaidi1.   

Abstract

The use of genetically manipulated mouse models, gene and protein discovery and the cataloguing of genetic mutations have each allowed us to obtain new insights into skeletal morphogenesis and remodeling. These techniques have made it possible to identify molecules that are obligatory for specific cellular functions, and to exploit these molecules for therapeutic purposes. New insights into the pathophysiology of diseases have also enabled us to understand molecular defects in a way that was not possible a decade ago. This review summarizes our current understanding of the carefully orchestrated cross-talk between cells of the bone marrow and between bone cells and the brain through which bone is constantly remodeled during adult life. It also highlights molecular aberrations that cause bone cells to become dysfunctional, as well as therapeutic options and opportunities to counteract skeletal loss.

Entities:  

Mesh:

Year:  2007        PMID: 17618270     DOI: 10.1038/nm1593

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  395 in total

Review 1.  T cells: critical bone regulators in health and disease.

Authors:  Roberto Pacifici
Journal:  Bone       Date:  2010-05-07       Impact factor: 4.398

2.  Calcium gluconate supplementation is effective to balance calcium homeostasis in patients with gastrectomy.

Authors:  M Krause; J Keller; B Beil; I van Driel; J Zustin; F Barvencik; T Schinke; M Amling
Journal:  Osteoporos Int       Date:  2014-11-13       Impact factor: 4.507

3.  Bone status in a mouse model of genetic hemochromatosis.

Authors:  P Guggenbuhl; P Fergelot; M Doyard; H Libouban; M-P Roth; Y Gallois; G Chalès; O Loréal; D Chappard
Journal:  Osteoporos Int       Date:  2010-10-26       Impact factor: 4.507

4.  Further evidence that FSH causes bone loss independently of low estrogen.

Authors:  Jameel Iqbal; Harry C Blair; Alberta Zallone; Li Sun; Mone Zaidi
Journal:  Endocrine       Date:  2012-02-21       Impact factor: 3.633

5.  RANKL employs distinct binding modes to engage RANK and the osteoprotegerin decoy receptor.

Authors:  Christopher A Nelson; Julia T Warren; Michael W-H Wang; Steven L Teitelbaum; Daved H Fremont
Journal:  Structure       Date:  2012-10-02       Impact factor: 5.006

6.  Implant-derived magnesium induces local neuronal production of CGRP to improve bone-fracture healing in rats.

Authors:  Yifeng Zhang; Jiankun Xu; Ye Chun Ruan; Mei Kuen Yu; Micheal O'Laughlin; Helen Wise; Di Chen; Li Tian; Dufang Shi; Jiali Wang; Sihui Chen; Jian Q Feng; Dick Ho Kiu Chow; Xinhui Xie; Lizhen Zheng; Le Huang; Shuo Huang; Kwoksui Leung; Na Lu; Lan Zhao; Huafang Li; Dewei Zhao; Xia Guo; Kaiming Chan; Frank Witte; Hsiao Chang Chan; Yufeng Zheng; Ling Qin
Journal:  Nat Med       Date:  2016-08-29       Impact factor: 53.440

Review 7.  Myeloma and Bone Disease.

Authors:  Cristina Panaroni; Andrew J Yee; Noopur S Raje
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

8.  Iron excess upregulates SPNS2 mRNA levels but reduces sphingosine-1-phosphate export in human osteoblastic MG-63 cells.

Authors:  L Peltier; C Bendavid; T Cavey; M-L Island; M Doyard; P Leroyer; C Allain; M De Tayrac; M Ropert; O Loréal; P Guggenbuhl
Journal:  Osteoporos Int       Date:  2018-05-03       Impact factor: 4.507

9.  Deletion of ferroportin in murine myeloid cells increases iron accumulation and stimulates osteoclastogenesis in vitro and in vivo.

Authors:  Lei Wang; Bin Fang; Toshifumi Fujiwara; Kimberly Krager; Akshita Gorantla; Chaoyuan Li; Jian Q Feng; Michael L Jennings; Jian Zhou; Nukhet Aykin-Burns; Haibo Zhao
Journal:  J Biol Chem       Date:  2018-05-03       Impact factor: 5.157

Review 10.  Actions of pituitary hormones beyond traditional targets.

Authors:  Mone Zaidi; Maria I New; Harry C Blair; Alberta Zallone; Ramkumarie Baliram; Terry F Davies; Christopher Cardozo; James Iqbal; Li Sun; Clifford J Rosen; Tony Yuen
Journal:  J Endocrinol       Date:  2018-03-19       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.